paclitaxel has been researched along with Androblastoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sakai, Y; Yamamoto, S | 1 |
Jeong, K; Lee, SR; Park, S | 1 |
2 other study(ies) available for paclitaxel and Androblastoma
Article | Year |
---|---|
Ovarian Sertoli-Leydig Cell Tumor With Heterologous Hepatocytes and a Hepatocellular Carcinomatous Element.
Topics: Aged; alpha-Fetoproteins; Antigens, Neoplasm; Antineoplastic Agents; Arginase; Biomarkers, Tumor; Carboplatin; Carcinoma, Hepatocellular; Female; Hepatocytes; Humans; Immunohistochemistry; Liver Neoplasms; Ovarian Neoplasms; Ovary; Paclitaxel; Sertoli-Leydig Cell Tumor; Tomography, X-Ray Computed | 2019 |
A Rare Case of Intra-Endometrial Leiomyoma of Uterus Simulating Degenerated Submucosal Leiomyoma Accompanied by a Large Sertoli-Leydig Cell Tumor.
Topics: Adenomyosis; Carboplatin; Female; Humans; Laparoscopy; Leiomyoma; Male; Menorrhagia; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Sertoli-Leydig Cell Tumor; Treatment Outcome; Uterine Neoplasms | 2016 |